• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

MedCap

481.20 SEK

+0.50 %

Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.50 %
-14.91 %
+5.41 %
-12.35 %
-13.45 %
+15.12 %
+76.91 %
+134.73 %
+4,664.36 %

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Read more
Market cap
7.26B SEK
Turnover
4.18M SEK
Revenue
2.11B
EBIT %
14.37 %
P/E
32.73
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/7
2026

Interim report Q2'26

23/10
2026

Interim report Q3'26

5/2
2027

Annual report '26

Regulatory press release5/29/2026, 6:30 AM

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release5/20/2026, 2:30 PM

Återköp av aktier i MedCap 15 maj 2026 - 20 maj 2026 – återköpsprogram avslutat

MedCap
Regulatory press release5/13/2026, 12:00 PM

Återköp av aktier i MedCap 7 maj 2026 – 13 maj 2026

MedCap

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/6/2026, 3:30 PM

MedCap beslutar om aktieåterköpsprogram

MedCap
Press release5/5/2026, 6:53 AM

Redeye: MedCap (Q1 review): Strong EBITA Growth, Poised for Acquisitions

MedCap
Regulatory press release5/4/2026, 3:30 PM

Stämmokommuniké årsstämma 4 maj 2026

MedCap
Regulatory press release4/29/2026, 4:30 AM

Strong result; EBITA increased by 30%

MedCap
Regulatory press release4/29/2026, 4:30 AM

Starkt resultat; EBITA ökade med 30%

MedCap
Regulatory press release3/30/2026, 6:30 AM

KALLELSE ÅRSSTÄMMA I MEDCAP AB (PUBL) DEN 4 MAJ 2026

MedCap
Regulatory press release3/25/2026, 2:00 PM

Ledningsförändringar i MedCap AB

MedCap
Regulatory press release3/23/2026, 7:30 AM

MedCap publicerar årsredovisning för 2025

MedCap
Press release2/11/2026, 12:33 PM

Redeye: MedCap (Q4 review): Beat on Solid Organic Growth

MedCap
Regulatory press release2/9/2026, 8:00 AM

Ledningsförändringar i MedCap AB

MedCap
Regulatory press release2/6/2026, 5:30 AM

Starkt resultat; EBITA ökade med 68% i kvartalet och 26% för helåret

MedCap
Regulatory press release2/6/2026, 5:30 AM

Strong results: EBITA increased by 68% for the quarter and 26% for the full year

MedCap
Regulatory press release12/30/2025, 7:30 AM

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release12/2/2025, 7:35 PM

Ledningsförändringar i MedCap AB

MedCap
Press release10/27/2025, 1:26 PM

Redeye: MedCap (Q3 review) - Healthy Q3 figures

MedCap
Regulatory press release10/24/2025, 4:30 AM

MedCap AB: Stark organisk och förvärvad tillväxt; EBITA ökade med 32%

MedCap
Regulatory press release10/24/2025, 4:30 AM

MedCap AB: Strong organic and acquired growth; EBITA increased by 32%

MedCap